INS and type 1 diabetes mellitus: In patients with type 1 diabetes, co-transplantation of ASC-derived insulin-secreting islets with hematopoietic stem cells decreased exogenous insulin requirement, increased c-peptide levels, and prevented ketoacidosis [26].